BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Avaxia Biologics, Inc. 

26 Pemberton Rd.

Wayland  Massachusetts  01778  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS










 Company News
Avaxia Biologics, Inc. Reports That Lead Product AVX-470 Achieves Objectives In Phase 1b Clinical Trial In Ulcerative Colitis 5/2/2014 11:50:25 AM
Avaxia Biologics, Inc. Awarded Patent With Broad Coverage Over Oral Anti-TNF Antibodies For Inflammatory Bowel Disease 2/11/2014 11:03:59 AM
Avaxia Biologics, Inc. Appoints Kevin Sarney, CPA, as Vice President, Finance and Administration 10/3/2013 7:28:58 AM
AbbVie (ABBV) Jumps Into $11.4 Million Series B for Avaxia Biologics, Inc. 6/7/2013 7:15:47 AM
Avaxia Biologics, Inc. Announces First Patient Dosed in Phase 1b Study of AVX-470 in Ulcerative Colitis 2/25/2013 11:09:30 AM
Avaxia Biologics, Inc. Raises $6.4 Million in Series B Financing 12/18/2012 6:44:10 AM
Avaxia Biologics, Inc. Receives IND Clearance From FDA to Initiate Clinical Program to Evaluate AVX-470 as Therapy for Ulcerative Colitis 11/27/2012 8:29:47 AM
Avaxia Biologics, Inc. is Awarded U.S. Patent for Antibody Therapy for Modulating Function of Intestinal Receptors and Methods of Treating Diabetes and Obesity 9/18/2012 10:15:25 AM
Avaxia Biologics, Inc. Announces Appointment of Michael D. Rivard as VP Corporate Development 6/13/2012 10:09:49 AM
Avaxia Biologics, Inc. is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation 5/23/2012 9:43:53 AM
123